Competitive Technologies, Inc. Enters Into Equity Purchase Agreement With Southridge Partners II
CTTC is the licensed distributor of the non-invasive Calmare ® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy" ® system developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. (The official "Scrambler Therapy" ® scientific and clinical information website is at http://www.scramblertherapy.org/english.htm .) The Calmare ® device is currently being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. For more information on the device, visit www.calmarett.com . Visit CTTC's website: www.competitivetech.net .
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended December 31, 2011, filed with the SEC on April 16, 2012, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
CONTACT: Direct inquiries to: Jean Wilczynski, IR Services, LLC (860.434.2465 / firstname.lastname@example.org)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts